Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 122,300 shares at $80.58 ($9.8M) on 2013-07-02, disclosed to the SEC on 2013-07-03.
Scheduled sale ($9.8M) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.94 | 13,950 | $1.1M | 11.3% |
| 2 | $79.52 | 68,985 | $5.5M | 56.2% |
| 3 | $80.58 | 39,365 | $3.2M | 32.5% |
| Total | $79.80 avg | 122,300 | $9.8M | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |